Steven Dowdy - Publications

Affiliations: 
Biomedical Sciences University of California, San Diego, La Jolla, CA 
Area:
Biochemistry

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Springer AD, Dowdy SF. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics. Nucleic Acid Therapeutics. PMID 29792572 DOI: 10.1089/nat.2018.0736  0.36
2017 Hagopian JC, Hamil AS, van den Berg A, Meade BR, Eguchi A, Palm-Apergi C, Dowdy SF. Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers. Nucleic Acid Therapeutics. PMID 28933656 DOI: 10.1089/nat.2017.0686  0.92
2016 Lönn P, Kacsinta AD, Cui XS, Hamil AS, Kaulich M, Gogoi K, Dowdy SF. Enhancing Endosomal Escape for Intracellular Delivery of Macromolecular Biologic Therapeutics. Scientific Reports. 6: 32301. PMID 27604151 DOI: 10.1038/srep32301  0.92
2016 Meitinger F, Anzola JV, Kaulich M, Richardson A, Stender JD, Benner C, Glass CK, Dowdy SF, Desai A, Shiau AK, Oegema K. 53BP1 and USP28 mediate p53 activation and G1 arrest after centrosome loss or extended mitotic duration. The Journal of Cell Biology. 214: 155-66. PMID 27432897 DOI: 10.1083/jcb.201604081  0.92
2016 Kacsinta AD, Dowdy SF. Current views on inducing synthetic lethal RNAi responses in the treatment of cancer. Expert Opinion On Biological Therapy. 16: 161-72. PMID 26630128 DOI: 10.1517/14712598.2016.1110141  0.92
2016 Hamil AS, Dowdy SF. Synthesis and Conjugation of Small Interfering Ribonucleic Neutral SiRNNs. Methods in Molecular Biology (Clifton, N.J.). 1364: 1-9. PMID 26472437 DOI: 10.1007/978-1-4939-3112-5_1  0.92
2015 Tobias IS, Kaulich M, Kim PK, Simon N, Jacinto E, Dowdy SF, King CC, Newton AC. Protein kinase Cζ exhibits constitutive phosphorylation and phosphatidylinositol-3,4,5-triphosphate-independent regulation. The Biochemical Journal. PMID 26635352 DOI: 10.1042/BJ20151013  0.92
2015 Kaulich M, Dowdy SF. Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing. Nucleic Acid Therapeutics. 25: 287-96. PMID 26540648 DOI: 10.1089/nat.2015.0545  0.92
2015 Lönn P, Dowdy SF. Cationic PTD/CPP-mediated macromolecular delivery: charging into the cell. Expert Opinion On Drug Delivery. 12: 1627-36. PMID 25994800 DOI: 10.1517/17425247.2015.1046431  0.92
2015 Kaulich M, Lee YJ, Lönn P, Springer AD, Meade BR, Dowdy SF. Efficient CRISPR-rAAV engineering of endogenous genes to study protein function by allele-specific RNAi. Nucleic Acids Research. 43: e45. PMID 25586224 DOI: 10.1093/nar/gku1403  0.92
2015 Shin D, Lönn P, Dowdy SF, Tor Y. Cellular activity of siRNA oligonucleotides containing synthetic isomorphic nucleoside surrogates. Chemical Communications (Cambridge, England). 51: 1662-5. PMID 25500944 DOI: 10.1039/c4cc08809c  0.92
2014 Meade BR, Gogoi K, Hamil AS, Palm-Apergi C, van den Berg A, Hagopian JC, Springer AD, Eguchi A, Kacsinta AD, Dowdy CF, Presente A, Lönn P, Kaulich M, Yoshioka N, Gros E, ... ... Dowdy SF, et al. Efficient delivery of RNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications. Nature Biotechnology. 32: 1256-61. PMID 25402614 DOI: 10.1038/nbt.3078  0.92
2014 Lönn P, Dowdy SF. 14. From bench to bedside: cationic TAT peptide transduction domain enters cells by macropinocytosis (2005): Original research article: Cationic TAT peptide transduction domain enters cells by macropinocytosis, 2005. Journal of Controlled Release : Official Journal of the Controlled Release Society. 190: 56-8. PMID 25356487  0.92
2014 Wu X, Zhang W, Font-Burgada J, Palmer T, Hamil AS, Biswas SK, Poidinger M, Borcherding N, Xie Q, Ellies LG, Lytle NK, Wu LW, Fox RG, Yang J, Dowdy SF, et al. Ubiquitin-conjugating enzyme Ubc13 controls breast cancer metastasis through a TAK1-p38 MAP kinase cascade. Proceedings of the National Academy of Sciences of the United States of America. 111: 13870-5. PMID 25189770 DOI: 10.1073/pnas.1414358111  0.92
2014 Narasimha AM, Kaulich M, Shapiro GS, Choi YJ, Sicinski P, Dowdy SF. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife. 3. PMID 24876129 DOI: 10.7554/eLife.02872  0.92
2014 Narasimha AM, Kaulich M, Shapiro GS, Choi YJ, Sicinski P, Dowdy SF. Cyclin D activates the Rb tumor suppressor by mono-phosphorylation Elife. 2014. DOI: 10.7554/eLife.02872.001  0.92
2014 Lön P, Dowdy SF. 14. from bench to bedside: Cationic TAT peptide transduction domain enters cells by macropinocytosis (2005): Original Research Article: Cationic TAT peptide transduction domain enters cells by macropinocytosis, 2005 References Journal of Controlled Release. 190: 56-58. DOI: 10.1016/j.jconrel.2014.07.026  0.92
2013 Kogiso T, Nagahara H, Otsuka M, Shiratori K, Dowdy SF. Transdifferentiation of human fibroblasts into hepatocyte-like cells by defined transcriptional factors. Hepatology International. 7: 937-44. PMID 26201932 DOI: 10.1007/s12072-013-9432-5  0.92
2013 Yoshioka N, Gros E, Li HR, Kumar S, Deacon DC, Maron C, Muotri AR, Chi NC, Fu XD, Yu BD, Dowdy SF. Efficient generation of human iPSCs by a synthetic self-replicative RNA. Cell Stem Cell. 13: 246-54. PMID 23910086 DOI: 10.1016/j.stem.2013.06.001  0.92
2013 Presente A, Dowdy SF. PTD/CPP peptide-mediated delivery of siRNAs. Current Pharmaceutical Design. 19: 2943-7. PMID 23140460 DOI: 10.2174/1381612811319160008  0.92
2012 Keerthivasan G, Liu H, Gump JM, Dowdy SF, Wickrema A, Crispino JD. A novel role for survivin in erythroblast enucleation. Haematologica. 97: 1471-9. PMID 22491741 DOI: 10.3324/haematol.2011.061093  0.92
2012 Palm-Apergi C, Lönn P, Dowdy SF. Do cell-penetrating peptides actually "penetrate" cellular membranes? Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 695-7. PMID 22472979 DOI: 10.1038/mt.2012.40  0.92
2010 June RK, Gogoi K, Eguchi A, Cui XS, Dowdy SF. Synthesis of a pH-sensitive nitrilotriacetic linker to peptide transduction domains to enable intracellular delivery of histidine imidazole ring-containing macromolecules. Journal of the American Chemical Society. 132: 10680-2. PMID 20681698 DOI: 10.1021/ja1040418  0.92
2010 Pawar SA, Sarkar TR, Balamurugan K, Sharan S, Wang J, Zhang Y, Dowdy SF, Huang AM, Sterneck E. C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proceedings of the National Academy of Sciences of the United States of America. 107: 9210-5. PMID 20439707 DOI: 10.1073/pnas.0913813107  0.92
2010 Eguchi A, Dowdy SF. Efficient siRNA delivery by novel PTD-DRBD fusion proteins. Cell Cycle (Georgetown, Tex.). 9: 424-5. PMID 20090414  0.92
2010 Gump JM, June RK, Dowdy SF. Revised role of glycosaminoglycans in TAT protein transduction domain-mediated cellular transduction. The Journal of Biological Chemistry. 285: 1500-7. PMID 19858185 DOI: 10.1074/jbc.M109.021964  0.92
2009 Meade BR, Dowdy SF. The road to therapeutic RNA interference (RNAi): Tackling the 800 pound siRNA delivery gorilla. Discovery Medicine. 8: 253-6. PMID 20040280  0.92
2009 Michiue H, Eguchi A, Scadeng M, Dowdy SF. Induction of in vivo synthetic lethal RNAi responses to treat glioblastoma. Cancer Biology & Therapy. 8: 2306-13. PMID 19901546  0.92
2009 Eguchi A, Dowdy SF. siRNA delivery using peptide transduction domains. Trends in Pharmacological Sciences. 30: 341-5. PMID 19545914 DOI: 10.1016/j.tips.2009.04.009  0.92
2009 Eguchi A, Meade BR, Chang YC, Fredrickson CT, Willert K, Puri N, Dowdy SF. Efficient siRNA delivery into primary cells by a peptide transduction domain-dsRNA binding domain fusion protein. Nature Biotechnology. 27: 567-71. PMID 19448630 DOI: 10.1038/nbt.1541  0.92
2009 Wagner MV, Smolka MB, de Bruin RA, Zhou H, Wittenberg C, Dowdy SF. Whi5 regulation by site specific CDK-phosphorylation in Saccharomyces cerevisiae. Plos One. 4: e4300. PMID 19172996 DOI: 10.1371/journal.pone.0004300  0.92
2009 Cerchietti LC, Yang SN, Shaknovich R, Hatzi K, Polo JM, Chadburn A, Dowdy SF, Melnick A. A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood. 113: 3397-405. PMID 18927431 DOI: 10.1182/blood-2008-07-168773  0.92
2008 Wadia JS, Schaller M, Williamson RA, Dowdy SF. Pathologic prion protein infects cells by lipid-raft dependent macropinocytosis. Plos One. 3: e3314. PMID 19390657 DOI: 10.1371/journal.pone.0003314  0.92
2008 Cerchietti LC, Polo JM, Da Silva GF, Farinha P, Shaknovich R, Gascoyne RD, Dowdy SF, Melnick A. Sequential transcription factor targeting for diffuse large B-cell lymphomas. Cancer Research. 68: 3361-9. PMID 18451163 DOI: 10.1158/0008-5472.CAN-07-5817  0.92
2008 Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Developmental Cell. 14: 159-69. PMID 18267085 DOI: 10.1016/j.devcel.2008.01.013  0.92
2008 Meade BR, Dowdy SF. Enhancing the cellular uptake of siRNA duplexes following noncovalent packaging with protein transduction domain peptides. Advanced Drug Delivery Reviews. 60: 530-6. PMID 18155315 DOI: 10.1016/j.addr.2007.10.004  0.92
2007 Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and therapeutic prospects. Trends in Molecular Medicine. 13: 443-8. PMID 17913584 DOI: 10.1016/j.molmed.2007.08.002  0.92
2007 Denicourt C, Saenz CC, Datnow B, Cui XS, Dowdy SF. Relocalized p27Kip1 tumor suppressor functions as a cytoplasmic metastatic oncogene in melanoma. Cancer Research. 67: 9238-43. PMID 17909030 DOI: 10.1158/0008-5472.CAN-07-1375  0.92
2007 Meade BR, Dowdy SF. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Advanced Drug Delivery Reviews. 59: 134-40. PMID 17451840 DOI: 10.1016/j.addr.2007.03.004  0.92
2007 Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood. 109: 5199-207. PMID 17317855 DOI: 10.1182/blood-2006-11-059378  0.92
2007 Haberichter T, Mädge B, Christopher RA, Yoshioka N, Dhiman A, Miller R, Gendelman R, Aksenov SV, Khalil IG, Dowdy SF. A systems biology dynamical model of mammalian G1 cell cycle progression. Molecular Systems Biology. 3: 84. PMID 17299420 DOI: 10.1038/msb4100126  0.92
2006 Dowdy SF. The anonymous American Idol manuscript reviewer. Cell. 127: 662-3; author reply . PMID 17110321 DOI: 10.1016/j.cell.2006.11.007  0.92
2006 Murriel CL, Dowdy SF. Influence of protein transduction domains on intracellular delivery of macromolecules. Expert Opinion On Drug Delivery. 3: 739-46. PMID 17076596 DOI: 10.1517/17425247.3.6.739  0.92
2006 Havens CG, Ho A, Yoshioka N, Dowdy SF. Regulation of late G1/S phase transition and APC Cdh1 by reactive oxygen species. Molecular and Cellular Biology. 26: 4701-11. PMID 16738333 DOI: 10.1128/MCB.00303-06  0.92
2006 Cai SR, Xu G, Becker-Hapak M, Ma M, Dowdy SF, McLeod HL. The kinetics and tissue distribution of protein transduction in mice. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 27: 311-9. PMID 16376528 DOI: 10.1016/j.ejps.2005.10.011  0.92
2006 Saenz CC, Dowdy SF. Transmembrane delivery of protein and peptide drugs into cancer cells Delivery of Protein and Peptide Drugs in Cancer. 225-254. DOI: 10.1142/9781860948039_0011  0.92
2005 Snyder EL, Saenz CC, Denicourt C, Meade BR, Cui XS, Kaplan IM, Dowdy SF. Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anticancer peptides. Cancer Research. 65: 10646-50. PMID 16322205 DOI: 10.1158/0008-5472.CAN-05-0118  0.92
2005 Snyder EL, Dowdy SF. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo. Expert Opinion On Drug Delivery. 2: 43-51. PMID 16296734 DOI: 10.1517/17425247.2.1.43  0.92
2005 Wadia JS, Dowdy SF. Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. Advanced Drug Delivery Reviews. 57: 579-96. PMID 15722165 DOI: 10.1016/j.addr.2004.10.005  0.92
2005 Kaplan IM, Wadia JS, Dowdy SF. Cationic TAT peptide transduction domain enters cells by macropinocytosis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 102: 247-53. PMID 15653149 DOI: 10.1016/j.jconrel.2004.10.018  0.92
2004 Denicourt C, Dowdy SF. Medicine. Targeting apoptotic pathways in cancer cells. Science (New York, N.Y.). 305: 1411-3. PMID 15353788 DOI: 10.1126/science.1102974  0.92
2004 Wadia JS, Wagner MV, Ezhevsky SA, Dowdy SF. Apoptin/VP3 contains a concentration-dependent nuclear localization signal (NLS), not a tumorigenic selective NLS Journal of Virology. 78: 6077-6078. PMID 15141008 DOI: 10.1128/JVI.78.11.6077-6078.2004  0.92
2004 Denicourt C, Dowdy SF. Cip/Kip proteins: more than just CDKs inhibitors. Genes & Development. 18: 851-5. PMID 15107401 DOI: 10.1101/gad.1205304  0.92
2004 Snyder EL, Dowdy SF. Cell penetrating peptides in drug delivery. Pharmaceutical Research. 21: 389-93. PMID 15070086 DOI: 10.1023/B:PHAM.0000019289.61978.f5  0.92
2004 Snyder EL, Meade BR, Saenz CC, Dowdy SF. Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide. Plos Biology. 2: E36. PMID 14966535 DOI: 10.1371/journal.pbio.0020036  0.92
2004 Wadia JS, Stan RV, Dowdy SF. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nature Medicine. 10: 310-5. PMID 14770178 DOI: 10.1038/nm996  0.92
2004 Katterle Y, Brandt BH, Dowdy SF, Niggemann B, Zänker KS, Dittmar T. Antitumour effects of PLC-γ1-(SH2)2-TAT fusion proteins on EGFR/c-erbB-2-positive breast cancer cells British Journal of Cancer. 90: 230-235. PMID 14710234 DOI: 10.1038/sj.bjc.6601506  0.92
2004 Wadia JS, Ezhevsky S, Dowdy SF. Delivery of novel anti-cancer peptides by protein transduction domains American Pharmaceutical Review. 7: 65-69.  0.92
2003 Becker-Hapak M, Dowdy SF. Protein transduction: generation of full-length transducible proteins using the TAT system. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. Unit 20.2. PMID 18228426 DOI: 10.1002/0471143030.cb2002s18  0.92
2003 Denicourt C, Dowdy SF. Another twist in the transforming growth factor beta-induced cell-cycle arrest chronicle. Proceedings of the National Academy of Sciences of the United States of America. 100: 15290-1. PMID 14676328 DOI: 10.1073/pnas.0307282100  0.92
2003 Yu BD, Becker-Hapak M, Snyder EL, Vooijs M, Denicourt C, Dowdy SF. Distinct and nonoverlapping roles for pRB and cyclin D:cyclin-dependent kinases 4/6 activity in melanocyte survival. Proceedings of the National Academy of Sciences of the United States of America. 100: 14881-6. PMID 14630948 DOI: 10.1073/pnas.2431391100  0.92
2003 Snyder EL, Meade BR, Dowdy SF. Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function. Journal of Controlled Release : Official Journal of the Controlled Release Society. 91: 45-51. PMID 12932636 DOI: 10.1016/S0168-3659(03)00212-8  0.92
2003 Denicourt C, Dowdy SF. Protein transduction technology offers novel therapeutic approach for brain ischemia. Trends in Pharmacological Sciences. 24: 216-8. PMID 12767717 DOI: 10.1016/S0165-6147(03)00074-9  0.92
2003 Wadia JS, Dowdy SF. Modulation of cellular function by TAT mediated transduction of full length proteins. Current Protein & Peptide Science. 4: 97-104. PMID 12678849 DOI: 10.2174/1389203033487289  0.92
2003 Tanaka Y, Dowdy SF, Linehan DC, Eberlein TJ, Goedegebuure PS. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells. Journal of Immunology (Baltimore, Md. : 1950). 170: 1291-8. PMID 12538688  0.92
2003 McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27(kip1) C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions. Molecular and Cellular Biology. 23: 216-28. PMID 12482975 DOI: 10.1128/MCB.23.1.216-228.2003  0.92
2002 Hsia CY, Cheng S, Owyang AM, Dowdy SF, Liou HC. c-Rel regulation of the cell cycle in primary mouse B lymphocytes. International Immunology. 14: 905-16. PMID 12147627  0.92
2002 Wadia JS, Dowdy SF. Protein transduction technology. Current Opinion in Biotechnology. 13: 52-6. PMID 11849958 DOI: 10.1016/S0958-1669(02)00284-7  0.92
2002 Ho A, Dowdy SF. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes. Current Opinion in Genetics & Development. 12: 47-52. PMID 11790554 DOI: 10.1016/S0959-437X(01)00263-5  0.92
2001 Klekotka PA, Santoro SA, Ho A, Dowdy SF, Zutter MM. Mammary epithelial cell-cycle progression via the alpha(2)beta(1) integrin: unique and synergistic roles of the alpha(2) cytoplasmic domain. The American Journal of Pathology. 159: 983-92. PMID 11549591  0.92
2001 Ezhevsky SA, Ho A, Becker-Hapak M, Davis PK, Dowdy SF. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Molecular and Cellular Biology. 21: 4773-84. PMID 11416152 DOI: 10.1128/MCB.21.14.4773-4784.2001  0.92
2001 Davis PK, Ho A, Dowdy SF. Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques. 30: 1322-6, 1328, 1330-1. PMID 11414226  0.92
2001 Abu-Amer Y, Dowdy SF, Ross FP, Clohisy JC, Teitelbaum SL. TAT Fusion Proteins Containing Tyrosine 42-deleted IκBα Arrest Osteoclastogenesis Journal of Biological Chemistry. 276: 30499-30503. PMID 11408488 DOI: 10.1074/jbc.M104725200  0.92
2001 Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods (San Diego, Calif.). 24: 247-56. PMID 11403574 DOI: 10.1006/meth.2001.1186  0.92
2001 Snyder EL, Dowdy SF. Protein/peptide transduction domains: Potential to deliver large DNA molecules into cells Current Opinion in Molecular Therapeutics. 3: 147-152. PMID 11338927  0.92
2001 Vocero-Akbani A, Chellaiah MA, Hruska KA, Dowdy SF. [2] Protein transduction: Delivery of Tat-GTPase fusion proteins into mammalian cells Methods in Enzymology. 332: 36-49. PMID 11305111 DOI: 10.1016/S0076-6879(01)32190-0  0.92
2001 Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF. Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo Cancer Research. 61: 474-477. PMID 11212234  0.92
2001 Davis PK, Dowdy SF. Molecules in focus: p73 International Journal of Biochemistry and Cell Biology. 33: 935-939. DOI: 10.1016/S1357-2725(01)00073-5  0.92
2001 Backus BD, Dowdy SF, Boschert KR, Richards TL, Becker-Hapak M. Safety guidance for laboratory personnel working with trans-activating transduction protein transduction domains Chemical Health and Safety. 8: 5-11. DOI: 10.1016/S1074-9098(00)00205-7  0.92
2000 Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF. A common E2F-1 and p73 pathway mediates cell death induced by TCR activation. Nature. 407: 642-5. PMID 11034214 DOI: 10.1038/35036608  0.92
2000 Vocero-Akbani A, Lissy NA, Dowdy SF. Transduction of full-length tat fusion proteins directly into mammalian cells: Analysis of T cell receptor activation-induced cell death Methods in Enzymology. 322: 508-521. PMID 10914043  0.92
2000 Schwarze SR, Hruska KA, Dowdy SF. Protein transduction: Unrestricted delivery into all cells? Trends in Cell Biology. 10: 290-295. PMID 10856932 DOI: 10.1016/S0962-8924(00)01771-2  0.92
2000 Schwarze SR, Dowdy SF. In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA Trends in Pharmacological Sciences. 21: 45-48. PMID 10664605 DOI: 10.1016/S0165-6147(99)01429-7  0.92
1999 Nagahara H, Ezhevsky SA, Vocero-Akbani AM, Kaldis P, Solomon MJ, Dowdy SF. Transforming growth factor β targeted inactivation of cyclin E:cyclin- dependent kinase 2 (Cdk2) complexes by inhibition of Cdk2 activating kinase activity Proceedings of the National Academy of Sciences of the United States of America. 96: 14961-14966. PMID 10611320 DOI: 10.1073/pnas.96.26.14961  0.92
1999 Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: Delivery of a biologically active protein into the mouse Science. 285: 1569-1572. PMID 10477521 DOI: 10.1126/science.285.5433.1569  0.92
1999 Gius DR, Ezhevsky SA, Becker-Hapak M, Nagahara H, Wei MC, Dowdy SF. Transduced p16(INK4a) peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1 Cancer Research. 59: 2577-2580. PMID 10363976  0.92
1999 Nagahara H, Latek RR, Ezhevsky SA, Dowdy SF. 2-D phosphopeptide mapping Methods in Molecular Biology (Clifton, N.J.). 112: 271-279. PMID 10027251  0.92
1998 Grakoui A, VanDyk LF, Dowdy SF, Allen PM. Molecular basis for the lack of T cell proliferation induced by an altered peptide ligand International Immunology. 10: 969-979. PMID 9701035 DOI: 10.1093/intimm/10.7.969  0.92
1997 Ezhevsky SA, Nagahara H, Vocero-Akbani AM, Gius DR, Wei MC, Dowdy SF. Hypo-phosphorylation of the retinoblastoma protein (pRb) by cyclin D:Cdk4/6 complexes results in active pRb Proceedings of the National Academy of Sciences of the United States of America. 94: 10699-10704. PMID 9380698 DOI: 10.1073/pnas.94.20.10699  0.92
1994 Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA. Function of a human cyclin gene as an oncogene Proceedings of the National Academy of Sciences of the United States of America. 91: 709-713. PMID 8290586  0.92
1994 Stanbridge E, Farmer A, Mills A, Loftus T, Kongkasuriyachai D, Dowdy S, Weissman B. Molecular characterization of QM, a novel gene with properties consistent with tumor suppressor function Cold Spring Harbor Symposia On Quantitative Biology. 59: 573-576. PMID 7587114  0.92
1994 Hatakeyama M, Herrera RA, Makela T, Dowdy SF, Jacks T, Weinberg RA. The cancer cell and the cell cycle clock. Cold Spring Harbor Symposia On Quantitative Biology. 59: 1-10. PMID 7587058  0.92
1993 Dowdy SF, Hinds PW, Louie K, Reed SI, Arnold A, Weinberg RA. Physical interaction of the retinoblastoma protein with human D cyclins. Cell. 73: 499-511. PMID 8490963 DOI: 10.1016/0092-8674(93)90137-F  0.92
1992 Cobrinik D, Dowdy SF, Hinds PW, Mittnacht S, Weinberg RA. The retinoblastoma protein and the regulation of cell cycling Trends in Biochemical Sciences. 17: 312-315. PMID 1412705 DOI: 10.1016/0968-0004(92)90443-D  0.92
1991 Mittnacht S, Hinds PW, Dowdy SF, Weinberg RA. Modulation of retinoblastoma protein activity during the cell cycle Cold Spring Harbor Symposia On Quantitative Biology. 56: 197-209. PMID 1819486  0.92
1991 Dowdy SF, Fasching CL, Araujo D, Lai KM, Livanos E, Weissman BE, Stanbridge EJ. Suppression of tumorigenicity in wilms tumor by the p15.5-p14 region of chromosome 11 Science. 254: 293-295. PMID 1656527  0.92
1991 Wheeler TT, Xiao JP, Dowdy SF, Stanbridge EJ, Young DA. Suppression of tumorigenicity of a Wilms' tumor cell line is associated with a decrease in synthesis of two proteins Oncogene. 6: 1903-1907. PMID 1656366  0.92
1991 Dowdy SF, Weissman BE, Stanbridge EJ. Correlation of the inability to sustain growth in defined serum-free medium with the suppression of tumorigenicity in Wilms' nephroblastoma Journal of Cellular Physiology. 147: 248-255. PMID 1645741  0.92
1990 Dowdy SF, Scanlon DJ, Fasching CL, Casey G, Stanbridge EJ. Irradiation microcell-mediated chromosome transfer (XMMCT): The generation of specific chromosomal arm deletions Genes Chromosomes and Cancer. 2: 318-327. PMID 2268580  0.92
Show low-probability matches.